Weight loss of 5% or more predicts loss of fat-free mass during palliative chemotherapy in patients with advanced cancer: A pilot study

Nutrition and Cancer

Volumn 64, Issue 6, 2012, Pages 826-832

  Buskermolen, Susanne ^a   Langius, Jacqueline A E ^a   Kruizenga, Hinke M ^a   Ligthart Melis, Gerdien C ^a   Heymans, Martijn W ^a   Verheul, Henk M W ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARM MUSCLE; ARTICLE; BODY MASS; BODY WEIGHT; CACHEXIA; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; DISEASE SEVERITY; FAT FREE MASS; FEMALE; GRIP STRENGTH; HUMAN; MALE; NUTRITIONAL STATUS; SURVIVAL RATE; WEIGHT REDUCTION;

AGED; CACHEXIA; FEMALE; HAND; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NUTRITIONAL STATUS; PALLIATIVE CARE; PILOT PROJECTS; WEIGHT LOSS;

EID: 84865263482     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.690062     Document Type: Article

References (36)

1. Stratton, R J, Green, C J, and, Elia, M. 2003. Disease-related malnutrition: An evidence-based approach to treatment, Wallingford, UK: CABI Publishing.
2. Slaviero, K A, Read, J A, Clarke, S J, and, Rivory, L P. 2003. Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapy. Nutr Cancer, 46: 148-157. (Pubitemid 37500508)
3. Persson, C, and, Glimelius, B. 2002. The relevance of weight loss for survival and quality of life in patients with advanced gastrointestinal cancer treated with palliative chemotherapy. Anticancer Res, 22: 3661-3668. (Pubitemid 36132846)
4. Dewys, W D, Begg, C, Lavin, P T, Band, P R, Bennett, J M. 1980. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med, 69: 491-497. (Pubitemid 10018703)
5. Ross, P J, Ashley, S, Norton, A, Priest, K, Waters, J S. 2004. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?. Br J Cancer, 90: 1905-1911. (Pubitemid 38746329)
6. Andreyev, H J, Norman, A R, Oates, J, and, Cunningham, D. 1998. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?. Eur J Cancer, 34: 503-509. (Pubitemid 28179346)
7. Deans, D A, Tan, B H, Wigmore, S J, Ross, J A, de Beaux, A C. 2009. The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer, 100: 63-69.
8. Gupta, D, Lis, C G, Vashi, P G, and, Lammersfeld, C A. 2010. Impact of improved nutritional status on survival in ovarian cancer. Support Care Cancer, 18: 373-381.
9. Nguyen, T V, and, Yueh, B. 2002. Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas. Cancer, 95: 553-562. (Pubitemid 34810180)
10. Arrieta, O, Michel Ortega, R M, Villanueva-Rodriguez, G, Serna-Thome, M G, Flores-Estrada, D. 2010. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small-cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer, 10
11. Evans, W J, Morley, J E, Argiles, J, Bales, C, Baracos, V. 2008. Cachexia: a new definition. Clin Nutr, 27: 793-799.
12. De Blaauw, I, Deutz, N E, and, Von Meyenfeldt, M F. 1997. Metabolic changes in cancer cachexiafirst of two parts. Clin Nutr, 16: 169-176. (Pubitemid 27417596)
13. De Blaauw, I, Deutz, N E, and, Von Meyenfeldt, M F. 1997. Metabolic changes of cancer cachexiasecond of two parts. Clin Nutr, 16: 223-228. (Pubitemid 28026672)
14. Kruizenga, H M, Seidell, J C, de Vet, H C, Wierdsma, N J, and, van Bokhorst-de van der Schueren, M A. 2005. Development and validation of a hospital screening tool for malnutrition: the short nutritional assessment questionnaire (SNAQ). Clin Nutr, 24: 75-82.
15. Hanai, T. 1968. Electrical properties of emulsions. In Emulsion Science, Edited by: Sherman, P. 353-477. London: Academic.
16. Bohannon, R W, Peolsson, A, Massy-Westropp, N, Desrosiers, J, and, Bear-Lehman, J. 2006. Reference values for adult grip strength measured with a Jamar dynamometer: a descriptive meta-analysis. Physiotherapy, 92: 11-15. (Pubitemid 44296151)
17. Frisancho, A R. 1981. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr, 34: 2540-2545. (Pubitemid 12176089)
18. Wilson, M M, Thomas, D R, Rubenstein, L Z, Chibnall, J T, Anderson, S. 2005. Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr, 82: 1074-1081. (Pubitemid 43779767)
19. Smets, E M, Garssen, B, Bonke, B, and, de Haes, J C. 1995. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res, 39: 315-325.
20. Burtis, C A, Ashwood, E R, and, Tietz, N W. 1994. Tietz Textbook of Clinical Chemistry, Philadelphia: W. B. Saunders Company.
21. Dati, F, Johnson, A M, and, Whicher, J T. 2001. The existing interim consensus reference ranges and the future approach. Clin Chem Lab Med, 39: 1134-1136. (Pubitemid 33133632)
22. Purich, D L, and, Allison, R D. 2000. Handbook of Biochemical Kinetics, San Diego, CA: Academic Press.
23. Schwarz, R, Krauss, O, and, Hinz, A. 2003. Fatigue in the general population. Onkologie, 26: 140-144. (Pubitemid 36677078)
24. Muscaritoli, M, Anker, S D, Argiles, J, Aversa, Z, Bauer, J M. 2010. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) cachexia-anorexia in chronic wasting diseases and nutrition in geriatrics. Clin Nutr, 29: 154-159.
25. Fearon, K, Strasser, F, Anker, S D, Bosaeus, I, Bruera, E. 2011. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol, 12: 489-495.
26. Halpern-Silveira, D, Susin, L R, Borges, L R, Paiva, S I, Assuncao, M C. 2009. Body weight and fat-free mass changes in a cohort of patients receiving chemotherapy. Support Care Cancer, 18: 617-625.
27. Goodpaster, B H, Park, S W, Harris, T B, Kritchevsky, S B, Nevitt, M. 2006. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci, 61: 1059-1064. (Pubitemid 44727214)
28. Read, J A, Choy, S TB, Beale, P J, and, Clarke, S J. 2006. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer, 55: 78-85. (Pubitemid 44477048)
29. Watson, W S, and, Sammon, A M. 1980. Body composition in cachexia resulting from malignant and nonmalignant diseases. Cancer, 46: 2041-2046. (Pubitemid 10025481)
30. Fearon, K C, Voss, A C, and, Hustead, D S. 2006. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr, 83: 1345-1350. (Pubitemid 44713065)
31. OGorman, P, McMillan, D C, and, Mcardle, C S. 1998. Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients. Nutr Cancer, 32: 76-80. (Pubitemid 29039504)
32. Berenstein, E G, and, Ortiz, Z. 2005. Megestrol acetate for the treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev, 18
33. Beck, S A, Smith, K L, and, Tisdale, M J. 1991. Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res, 51: 6089-6093.
34. Silva, JdAP, Trindade, EBSdM, Fabre, MEdS, Menegotto, V M, Gevaerd, S. 2012. Fish oil supplement alters markers of inflammatory and nutritional status in colorectal cancer patients. Nutr Cancer, 64: 267-273.
35. van der Meij, B S, Langius, J A, Smit, E F, Spreeuwenberg, M D, von Blomberg, B M. 2010. Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. J Nutr, 140: 1774-1780.
36. Ryan, A M, Reynolds, J V, Healy, L, Byrne, M, Moore, J. 2009. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg, 249: 355-363.